Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH

Clinical trial NCT06104319 · COMPLETED

Trial details

NCT number: NCT06104319
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-alcoholic Fatty Liver Disease

Start date: 2024-01-22
Primary completion: 2025-09-23
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.